MASS
Healthcare908 Devices Inc.
$5.48
+$0.39 (+7.66%)
Jan 5, 2026
Price History (1Y)
Analysis
908 Devices Inc. is a company in the Healthcare sector, specifically within the Medical Devices industry. The company has a market capitalization of $198.34 million and generates revenue of $65.05 million on an annualized basis. It employs 246 individuals. The financial performance of 908 Devices Inc. is marked by significant losses, with net income at -$72,745,000 and EBITDA at -$43,726,000 in the trailing twelve months. The company's operating margin stands at -40.1% and profit margin at -6.4%. Returns on equity and assets are negative at -54.4% and -16.4%, respectively. The balance sheet shows a debt-to-equity ratio of 3.19, with cash reserves totaling $112.05 million and debt amounting to $4.35 million. The valuation metrics for 908 Devices Inc. include a forward P/E ratio of -21.08 and an EV/EBITDA ratio of -1.75. The company's revenue growth rate is -3.5% on a year-over-year basis, with no earnings growth data available.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About 908 Devices Inc.
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices for use in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as process fingerprint data to support large-scale efforts in predictive bioprocess modeling. The company's products comprise Maven, an on-line device for bioprocess monitoring and control; Trace C2, an on-line monitoring of methanol or ethanol and control of substrate feeding in fermentation processes; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Visit website →Key Statistics
- Market Cap
- $198.34M
- P/E Ratio
- N/A
- 52-Week High
- $9.34
- 52-Week Low
- $1.92
- Avg Volume
- 417.11K
- Beta
- 0.48
Company Info
- Industry
- Medical Devices
- Exchange
- NGM
- Country
- United States
- Employees
- 246